Why Is a Heart Surgeon on Your Infective Endocarditis Team?
At a Glance
A cardiothoracic surgeon may join an infective endocarditis team early to assess valve damage, ongoing infection, and the risk that infected material could block a blood vessel. Their involvement helps plan care but does not mean surgery is inevitable; some patients continue antibiotics alone.
In this answer
3 sections
It is completely understandable to feel anxious if a heart surgeon is assigned to your care team while you are only receiving antibiotics, but their presence does not mean that surgery is inevitable. Current medical guidelines recommend that infective endocarditis be treated by a collaborative group of specialists known as an “Endocarditis Team” [1][2][3]. A cardiothoracic surgeon is often a member of this team. They are involved early to assess your case, discuss potential surgical options, and help arrange prompt treatment if your condition changes and surgery becomes necessary.
The Multidisciplinary Endocarditis Team
Treating infective endocarditis is highly complex. Guidelines recommend that patients be managed by a specialized group of experts working closely together [1][2]. Depending on the hospital, this team typically includes infectious disease specialists, cardiologists (heart doctors), microbiologists, imaging specialists, and cardiothoracic (heart) surgeons [1][3].
By collaborating, the team reviews your case from multiple perspectives. This helps ensure that you receive the most effective targeted antibiotic therapy (antibiotics specifically chosen to fight your exact bacteria), the right imaging tests (such as echocardiograms, which are ultrasounds of the heart), and the correct level of follow-up. Observational studies suggest that having a specialized endocarditis team involved is associated with improved survival rates and faster delivery of necessary treatments, even for patients managed mainly with medication [4][2][5].
Why Early Surgical Evaluation Matters
Even when antibiotics are the primary treatment, infective endocarditis can change unpredictably. A surgeon may be consulted early as a proactive measure, or because of a specific finding on your tests. While your infectious disease doctor focuses on clearing the bacteria, the surgeon is evaluating your case for complications that might make an operation a safer choice than antibiotics alone. These include:
- Heart failure: If the infection severely damages the heart valves, causing them to leak or fail, surgery may be necessary to repair or replace the valve [6][7]. Heart failure is a major reason for early surgical evaluation [6][8].
- Persistent infection: Sometimes, antibiotics are not enough to eliminate the infection. If your blood cultures (blood tests repeated to see whether bacteria are still present) remain positive or you continue to have fevers despite several days of appropriate antibiotics, the team may reassess whether surgery is appropriate to remove the infected tissue [6][7][9]. The decision is highly individualized and not based solely on the number of days you have had a fever.
- Risk of embolism: The infection can form clumps of bacteria and tissue on the heart valves called vegetations. If these vegetations are large or considered high-risk, fragments (called emboli) can break off and block blood vessels. If an embolus travels to the brain, it can cause a stroke. Surgery may be considered to remove the vegetation, but it is not automatic. The team will weigh the size and mobility of the vegetation against the risks of surgery [6][10][11].
Having a surgeon involved early allows for shared planning. It means that if your health worsens, the team is already familiar with your case and can arrange timely escalation of your care [9][12]. Research shows that involving a multidisciplinary team helps identify patients who need surgery more effectively [13][5].
What This Means for You
Seeing a surgeon on your team is a sign that you are receiving guideline-directed care (care based on current expert recommendations) [14][15]. The surgeon is a partner in your recovery. They may review your scans, ask about your symptoms, explain what would trigger surgery, and then recommend continuing medical treatment. If surgery is never needed, they simply remain part of the team’s contingency planning.
Urgent Symptoms to Report
Do not wait for your next routine appointment or bedside visit if you experience sudden changes. Notify your inpatient care team immediately (or seek emergency help if you are outside the hospital) if you develop:
- Sudden or worsening shortness of breath
- Chest pain
- Fainting or severe dizziness
- Sudden weakness, confusion, or trouble speaking
- Severe new headache
- Persistent high fever or chills
These symptoms may signal complications like heart failure, an embolism, or uncontrolled infection, and require prompt medical attention.
Common questions in this guide
Why is a heart surgeon involved if I am being treated with antibiotics?
Does seeing a cardiothoracic surgeon mean I will need heart surgery?
What findings could lead to surgery for infective endocarditis?
How do doctors monitor whether my endocarditis treatment is working?
What symptoms should I report urgently while being treated for endocarditis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was I referred to you as a routine part of the team's process, or because of a specific finding in my echocardiogram, valve, cultures, or symptoms?
- 2.What specific signs or test results would cause you to recommend surgery rather than continuing with antibiotics alone?
- 3.How often will the care team be checking my echocardiograms and blood cultures to monitor my progress?
- 4.What is my current estimated surgical risk, and what are the risks of waiting?
- 5.What findings currently support continuing with just medical therapy?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
2023 European Society of Cardiology guidelines for the management of infective endocarditis : Statement of endorsement by the NVVC Full version.
Peijster AJL, van Nieuwkoop C, Keunen RWM, et al.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2026; (34(Suppl 1)):1-13 doi:10.1007/s12471-025-02010-w.
PMID: 41410976 - 2
[Contribution of the new guidelines for the management of infective endocarditis].
Selton-Suty C, Duval X, Hoen B
La Revue du praticien 2017; (67(2)):183-190.
PMID: 30512855 - 3
Surgical Implications of the 2023 ESC Endocarditis Guidelines Endorsed by EACTS: Bridging Guidelines and Practice.
de la Cuesta M, Marin-Cuartas M, de Waha S, et al.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2025; (67(7)) doi:10.1093/ejcts/ezaf225.
PMID: 40608489 - 4
The endocarditis team: a review.
Maher A, Baddour LM, El Dalati S, et al.
Expert review of anti-infective therapy 2026; (24(9)):801-812 doi:10.1080/14787210.2026.2695437.
PMID: 42345234 - 5
Inception of the 'endocarditis team' is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study.
Kaura A, Byrne J, Fife A, et al.
Open heart 2017; (4(2)):e000699 doi:10.1136/openhrt-2017-000699.
PMID: 29344368 - 6
Indications of Surgery in Infective Endocarditis.
Bin Abdulhak AA, Tleyjeh IM
Current infectious disease reports 2017; (19(3)):10 doi:10.1007/s11908-017-0569-6.
PMID: 28251509 - 7
[Surgical Treatment for Infective Endocarditis].
Shibasaki I
Kyobu geka. The Japanese journal of thoracic surgery 2022; (75(10)):763-767.
PMID: 36155566 - 8
Infective endocarditis complicated by shock: a systematic review and meta-analysis.
Pîrîianu-Masgras RB, Mebazaa A, Savarese G, et al.
Heart failure reviews 2025; (30(6)):1377-1395 doi:10.1007/s10741-025-10556-5.
PMID: 40884710 - 9
The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice.
Imazio M
Journal of cardiovascular medicine (Hagerstown, Md.) 2024; (25(10)):718-726 doi:10.2459/JCM.0000000000001651.
PMID: 38916201 - 10
Early surgery to prevent embolic events in patients with infective endocarditis: a comprehensive review.
Nielsen ST, Hadji-Turdeghal K, Graversen PL, et al.
Journal of cardiothoracic surgery 2024; (19(1)):463 doi:10.1186/s13019-024-02946-x.
PMID: 39034421 - 11
Embolic Events in Infective Endocarditis: A Comprehensive Review.
Cabezon G, Pulido P, López Díaz J, et al.
Reviews in cardiovascular medicine 2024; (25(3)):97 doi:10.31083/j.rcm2503097.
PMID: 39076945 - 12
Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines.
Wang A, Fosbøl EL
European heart journal 2022; (43(17)):1617-1625 doi:10.1093/eurheartj/ehab898.
PMID: 35029274 - 13
Impact of multidisciplinary Endocarditis Team on management of infective endocarditis.
Fourré N, Zimmermann V, Guery B, et al.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2024; (28(5)):103870 doi:10.1016/j.bjid.2024.103870.
PMID: 39313026 - 14
The impact of implementing an endocarditis team in comparison to the classic heart team in a tertiary referral centre.
van den Heuvel FMA, Bos M, Geuzebroek GSC, et al.
BMC cardiovascular disorders 2022; (22(1)):114 doi:10.1186/s12872-022-02558-0.
PMID: 35300594 - 15
[Impact of a dedicated multidisciplinary committee (endocarditis team) on the management and outcome of infective endocarditis in a reference center].
Iglesias-Varea J, Fernández-Ruiz M, Domínguez L, et al.
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2025; (38(4)):294-304 doi:10.37201/req/020.2025.
PMID: 40432449
This page explains why a cardiothoracic surgeon may join an infective endocarditis care team for educational purposes and does not replace medical advice. Ask your treating team how these recommendations apply to your specific situation.
Get notified when new evidence is published on Infective endocarditis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.